Stock Incentive Plan - Schedule of Information Regarding Restricted Stock Activity (Detail) |
12 Months Ended |
|---|---|
|
Dec. 31, 2019
USD ($)
$ / shares
shares
| |
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
| Outstanding Shares, Granted | shares | 497,051 |
| Outstanding Shares, Lapse of restrictions | shares | (389,061) |
| Outstanding Shares, Ending Balance | shares | 107,990 |
| Weighted Average Grant Date Fair Value, Granted | $ / shares | $ 2.02 |
| Weighted Average Grant Date Fair Value, Lapse of restrictions | $ / shares | 2.07 |
| Weighted Average Grant Date Fair Value, Ending Balance | $ / shares | $ 1.85 |
| Weighted Average Contractual Life Remaining | 1 year 8 months 1 day |
| Aggregate Intrinsic Value, Granted | $ | $ 1,006 |
| Aggregate Intrinsic Value, Lapse of restrictions | $ | 919 |
| Aggregate Intrinsic Value, Ending Balance | $ | $ 156 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options granted in period intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options lapse of restrictions in period weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|